Mehmet Soylu

Dr. Mehmet Soylu

Faculty of Medicine Department of Microbiology, Ege University, İzmir, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2025 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
Reyhan GümüşburunReyhan Gümüşburun
Reyhan Gümüşburun
OYOnurcan Yıldırım
Onurcan Yıldırım
MKMetehan Karakoc
Metehan Karakoc
KOKasım Okan
Kasım Okan
SISinem Inan
Sinem Inan
OAOmur Ardeniz
Omur Ardeniz
Purpose Inborn Errors of Immunity (IEI) often lead to recurrent infections, immune dysregulation, and an increased risk of malignancies. Due to the heterogeneity in IEI presentations, personalized monitoring is essential for early detection of non-infectious complications. This study aims to document the characteristics and prevalence of malignancies in IEI patients. Methods A retrospective review of 355 patients diagnosed with IEI at the Adult Allergy and Immunology Clinic of Ege University was conducted. Data on demographics, clinical presentations, laboratory results, and immunological and genetic profiles of patients with malignancies were analyzed. Results A total of 40 patients with neoplasia (F/M: 18/22; median age: 51.58 years, range: 18–91) were evaluated. The median ages at IEI symptom onset, diagnosis, and neoplasm diagnosis were 16.5, 45, and 39.5 years, respectively. Malignancy was diagnosed in 60% of patients before IEI, with referrals for low immunoglobulin levels and/or severe infections, and for a genetic profile suggestive of immunodeficiency. The prevalence of malignancy in the overall cohort was 10.42% (37/355), while it was significantly higher in the common variable immunodeficiency (CVID) subgroup, reaching 20.44% (28/137). Lymphoma was the most common malignancy at 45.9%, primarily non-Hodgkin lymphoma (NHL) at 40.5%, with diffuse large B-cell lymphoma (DLBCL) as a key subtype; carcinomas were the second most common at 35.1%. Hematologic malignancies were significantly more frequent among patients with CVID (90.5%), whereas non-hematologic malignancies predominated in the non-CVID group (77.8%) (p = 0.024). Lymphoproliferation was more common in hematologic malignancies (85.7%) compared to non-hematologic malignancies (25.0%) (p < 0.001). Genetic variants were identified in 61% of cases, with 37% classified as pathogenic or likely pathogenic, including variants in TNFRSF13B/TACI, CCDC40, PLCG2, ATM, CARD11, CHEK2, CNV, COPB1, HPS5, LYST, MAPK8IP1, NBS1, NF1, NFKBIA, PI4KA, POLE, SPI1, and TAP2. Conclusions Findings confirm that NHL, particularly DLBCL, is the most prevalent malignancy in this cohort. Given the link between malignancies and underlying IEI, immunologic evaluation is recommended, particularly for NHL patients. The observed predominance of hematologic malignancies among CVID patients and the association with lymphoproliferation further emphasize the need for heightened malignancy surveillance and early immunologic workup in this subgroup. Further research on biomarkers for malignancy prediction in IEI is warranted.

23 October 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
NYNisel Yılmaz
Nisel Yılmaz
GGGülşen Altınkanat Gelmez
Gülşen Altınkanat Gelmez
GSGüner Söyletir
Güner Söyletir
AIArzu İlki
Arzu İlki
ATAynur Eren Topkaya
Aynur Eren Topkaya
ZKZehra Kipritçi
Zehra Kipritçi
Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.

14 May 2020 in The Journal of Pediatric Research
Verified
Journal Article
Closed access
GAGülhadiye Avcu
Gülhadiye Avcu
MSMehmet Soylu
Mehmet Soylu
ŞAŞöhret Aydemir
Şöhret Aydemir
DKDeniz Yılmaz Karapınar
Deniz Yılmaz Karapınar
ZBZumrut Sahbudak Bal
Zumrut Sahbudak Bal
FVFadıl Vardar
Fadıl Vardar

13 April 2023 in Transplantation Proceedings
Verified
Journal Article
Closed access
HGHalil Goksel Guzel
Halil Goksel Guzel
VYVural Taner Yilmaz
Vural Taner Yilmaz
SKSadi Koksoy
Sadi Koksoy
HKHuseyin Kocak
Huseyin Kocak
AKAbdullah Kisaoglu
Abdullah Kisaoglu
GSGultekin Suleymanlar
Gultekin Suleymanlar

15 October 2025 in PeerJ
Verified
Journal Article
Open access
PDF file
MSMehmet Soylu
Mehmet Soylu
ABAhmet Selman Bozkir
Ahmet Selman Bozkir
Deep learning offers promising potential for automating the interpretation of immunoglobulin A (IgA) endomysial antibody (EMA) tests, a critical serological test for the diagnosis of celiac disease that currently requires labor-intensive and subjective human interpretation. In this study, we employ and comprehensively evaluate the performance of the EfficientNet and EfficientNetV2 architectures in binary (positive vs negative, where all weak and strong positive signals were grouped as positive), three-class (negative, weak positive, strong positive), and four-class (negative, weak positive, strong positive and gray zone) classification scenarios using immunofluorescence images of IgA EMA equivalent (EMA-eq) tests. Our experiments on 368 clinical samples show high performance, with EfficientNetV2-S achieving an accuracy of 99.37% in binary classification, 95.28% in three-class classification, and 86.98% in the complex four-class scenario that introduces gray zone cases as a distinct interpretive category. Contrary to conventional assumptions, medium-sized deep architectures consistently outperformed their larger counterparts. The superior performance of the EfficientNet-V2 models can be attributed to their architectural innovations and higher input resolution (640 × 640 pixels), which proved critical for capturing subtle immunofluorescence patterns. We also incorporate HiRes-CAM (Class Activation Mapping), a convolutional neural network oriented visual explanation tool, to better understand the decisions of the underlying trained deep learning model in an explainable artificial intelligence (AI) manner. This study demonstrates that deep learning has the potential to achieve expert-level performance in EMA-eq test interpretation, offering a path toward more standardized, efficient and objective celiac disease diagnosis while reducing the burden on specialist medical staff.

30 September 2021 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
CCCandan Cicek
Candan Cicek
MSMehmet Soylu
Mehmet Soylu
MÖMuhammed Alper Özarslan
Muhammed Alper Özarslan
MMMerve Mert
Merve Mert
MBMukerrem Bahar Baskir
Mukerrem Bahar Baskir
ANAyşe Noyan
Ayşe Noyan